Free Trial
→ June 12: $100 Turns Into $100,000? (From Brownstone Research) (Ad)tc pixel Free SYRA Stock Alerts

Syra Health (SYRA) Competitors

Syra Health logo
$0.49 0.00 (0.00%)
As of 05/22/2026 03:59 PM Eastern
Compare

SYRA vs. ZGM, MOBQ, CIGL, WHLM, and SGRP

Should you buy Syra Health stock or one of its competitors? MarketBeat compares Syra Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Syra Health include Zenta Group (ZGM), Mobiquity Technologies (MOBQ), Concorde International Group (CIGL), Wilhelmina International (WHLM), and SPAR Group (SGRP). These companies are all part of the "business services" industry.

How does Syra Health compare to Zenta Group?

Zenta Group (NASDAQ:ZGM) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

Zenta Group has higher earnings, but lower revenue than Syra Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zenta GroupN/AN/AN/AN/AN/A
Syra Health$7.98M0.85-$2.94M-$0.02N/A

Zenta Group has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Zenta Group's return on equity of 0.00% beat Syra Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Zenta GroupN/A N/A N/A
Syra Health -54.90%-131.94%-99.19%

In the previous week, Syra Health had 1 more articles in the media than Zenta Group. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Zenta Group. Syra Health's average media sentiment score of 1.11 beat Zenta Group's score of 0.00 indicating that Syra Health is being referred to more favorably in the news media.

Company Overall Sentiment
Zenta Group Neutral
Syra Health Positive

4.8% of Syra Health shares are owned by institutional investors. 24.6% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zenta Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Syra Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Syra Health beats Zenta Group on 5 of the 9 factors compared between the two stocks.

How does Syra Health compare to Mobiquity Technologies?

Syra Health (NASDAQ:SYRA) and Mobiquity Technologies (NASDAQ:MOBQ) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Syra Health has a beta of 3.1, indicating that its share price is 210% more volatile than the broader market. Comparatively, Mobiquity Technologies has a beta of 2.19, indicating that its share price is 119% more volatile than the broader market.

Syra Health has higher revenue and earnings than Mobiquity Technologies. Syra Health is trading at a lower price-to-earnings ratio than Mobiquity Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Syra Health$7.98M0.85-$2.94M-$0.02N/A
Mobiquity Technologies$1.24M15.01-$6.53M-$0.48N/A

4.8% of Syra Health shares are owned by institutional investors. Comparatively, 14.2% of Mobiquity Technologies shares are owned by institutional investors. 24.6% of Syra Health shares are owned by insiders. Comparatively, 24.5% of Mobiquity Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Syra Health has a net margin of -54.90% compared to Mobiquity Technologies' net margin of -279.27%. Syra Health's return on equity of -131.94% beat Mobiquity Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Syra Health-54.90% -131.94% -99.19%
Mobiquity Technologies -279.27%-212.32%-90.57%

In the previous week, Syra Health had 1 more articles in the media than Mobiquity Technologies. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Mobiquity Technologies. Syra Health's average media sentiment score of 1.11 beat Mobiquity Technologies' score of 0.21 indicating that Syra Health is being referred to more favorably in the media.

Company Overall Sentiment
Syra Health Positive
Mobiquity Technologies Neutral

Summary

Syra Health beats Mobiquity Technologies on 9 of the 13 factors compared between the two stocks.

How does Syra Health compare to Concorde International Group?

Syra Health (NASDAQ:SYRA) and Concorde International Group (NASDAQ:CIGL) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

4.8% of Syra Health shares are owned by institutional investors. 24.6% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Concorde International Group has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Concorde International Group's return on equity of 0.00% beat Syra Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Syra Health-54.90% -131.94% -99.19%
Concorde International Group N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syra Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Concorde International Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Concorde International Group had 1 more articles in the media than Syra Health. MarketBeat recorded 2 mentions for Concorde International Group and 1 mentions for Syra Health. Concorde International Group's average media sentiment score of 1.77 beat Syra Health's score of 1.11 indicating that Concorde International Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Syra Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concorde International Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Syra Health has higher earnings, but lower revenue than Concorde International Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Syra Health$7.98M0.85-$2.94M-$0.02N/A
Concorde International Group$11.07M1.35-$83.64MN/AN/A

Summary

Concorde International Group beats Syra Health on 8 of the 11 factors compared between the two stocks.

How does Syra Health compare to Wilhelmina International?

Wilhelmina International (NASDAQ:WHLM) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Wilhelmina International has a net margin of 3.38% compared to Syra Health's net margin of -54.90%. Wilhelmina International's return on equity of 2.29% beat Syra Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Wilhelmina International3.38% 2.29% 1.40%
Syra Health -54.90%-131.94%-99.19%

20.0% of Wilhelmina International shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 49.4% of Wilhelmina International shares are owned by company insiders. Comparatively, 24.6% of Syra Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Syra Health had 1 more articles in the media than Wilhelmina International. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for Wilhelmina International. Syra Health's average media sentiment score of 1.11 beat Wilhelmina International's score of 0.00 indicating that Syra Health is being referred to more favorably in the news media.

Company Overall Sentiment
Wilhelmina International Neutral
Syra Health Positive

Wilhelmina International has higher revenue and earnings than Syra Health. Syra Health is trading at a lower price-to-earnings ratio than Wilhelmina International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wilhelmina International$17.09M1.02$430K$0.1027.45
Syra Health$7.98M0.85-$2.94M-$0.02N/A

Wilhelmina International has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Syra Health has a beta of 3.1, suggesting that its stock price is 210% more volatile than the broader market.

Summary

Wilhelmina International beats Syra Health on 10 of the 13 factors compared between the two stocks.

How does Syra Health compare to SPAR Group?

Syra Health (NASDAQ:SYRA) and SPAR Group (NASDAQ:SGRP) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Syra Health has higher earnings, but lower revenue than SPAR Group. Syra Health is trading at a lower price-to-earnings ratio than SPAR Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Syra Health$7.98M0.85-$2.94M-$0.02N/A
SPAR Group$136.10M0.13-$24.63M-$1.03N/A

Syra Health has a beta of 3.1, indicating that its stock price is 210% more volatile than the broader market. Comparatively, SPAR Group has a beta of 0.18, indicating that its stock price is 82% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Syra Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
SPAR Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

SPAR Group has a net margin of -18.51% compared to Syra Health's net margin of -54.90%. SPAR Group's return on equity of -107.74% beat Syra Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Syra Health-54.90% -131.94% -99.19%
SPAR Group -18.51%-107.74%-19.90%

In the previous week, Syra Health and Syra Health both had 1 articles in the media. Syra Health's average media sentiment score of 1.11 beat SPAR Group's score of 0.00 indicating that Syra Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Syra Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SPAR Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

4.8% of Syra Health shares are held by institutional investors. Comparatively, 9.6% of SPAR Group shares are held by institutional investors. 24.6% of Syra Health shares are held by company insiders. Comparatively, 50.9% of SPAR Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

SPAR Group beats Syra Health on 8 of the 13 factors compared between the two stocks.

Get Syra Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYRA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYRA vs. The Competition

Export
MetricSyra HealthEmployment agencies IndustryMedical SectorNASDAQ Exchange
Market Cap$6.82M$16.25M$6.46B$12.34B
Dividend YieldN/AN/A2.76%5.28%
P/E Ratio-0.76N/A21.0025.66
Price / Sales0.850.57562.1886.31
Price / CashN/AN/A43.4956.67
Price / Book0.790.5510.417.14
Net Income-$2.94M-$13.52M$3.57B$335.98M
7 Day Performance28.26%13.85%6.40%4.11%
1 Month Performance4.79%1.82%3.54%2.52%
1 Year PerformanceN/A19.30%34.14%35.04%

Syra Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYRA
Syra Health
N/A$0.49
flat		N/A+414.6%$6.82M$7.98MN/A78
ZGM
Zenta Group
N/A$1.62
-1.6%		N/AN/A$18.81MN/AN/A9
MOBQ
Mobiquity Technologies
N/A$0.67
-0.6%		N/A-60.6%$18.65M$1.24MN/A10
CIGL
Concorde International Group
N/A$0.81
-1.6%		N/A-88.7%$17.93M$11.07MN/A134
WHLM
Wilhelmina International
N/A$2.75
flat		N/AN/A$17.47M$17.09M22.8880

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SYRA) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel
Skip the Line Opportunity: The SpaceX IPO
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel